Medical Journals

Effect of the Selective Dopamine D3 Receptor Antagonist Sb-277011-a on Regional C-fos-like Expression in Rat Forebrain.

Authors:
  • Southam Eric
  • Lloyd Andrew
  • Jennings Carol A
  • Cluderay Jane E
  • Cilia Jackie
  • Gartlon Jane E
  • Jones Declan N C

From: Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park North, Harlow, Essex, CM19 5AW, UK. eric_2_southam@gsk.com

Brain research

  • Publish Date: May 2007
  • ISSN: 0006-8993
  • Volume: 1149
  • Issue:
  • Pages: 50-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Southam Eric, Lloyd Andrew, Jennings Carol A, et al. Effect of the Selective Dopamine D3 Receptor Antagonist Sb-277011-a on Regional C-fos-like Expression in Rat Forebrain.. Brain Res. May 2007;1149:50-7

Abstract

SB-277011-A is a dopamine D(3) receptor antagonist that exhibits over 100-fold selectivity over dopamine D(2) receptors and a broad spectrum of other receptor, ion channels, and enzymes. We employed c-Fos immunohistochemistry to characterise the functional neuroanatomical effects of acute administration of SB-277011-A and observed a time-dependent increase in the density of c-Fos-like positive nuclei in rat forebrain with maximal effects observed 2 h post-dose. The relative influence of the different brain regions on the overall effect of SB-277011-A was ranked by partial least squares discriminant analysis loadings plot which indicated that sites within the nucleus accumbens exerted the greatest influence on the separation of the vehicle and SB-277011-A treatment groups. At the 2 h time-point, c-Fos-like expression was shown to be significantly elevated (p<0.05) in the core and shell of the nucleus accumbens, at both rostral and caudal levels, and in the lateral septum. No significant changes were detected in the caudate nucleus (lateral or medial) or in the cingulate, infralimbic prefrontal, or somatosensory cortices. The capacity of SB-277011-A to trigger immediate early gene expression in these limbic regions of rat brain adds to a growing consensus of the potential utility of dopamine D(3) receptor antagonism in psychiatric disorders including schizophrenia and drug dependency.

Mesh Headings (Keywords): Animals, Immunohistochemistry, Male, Nitriles, Prosencephalon, Proto-Oncogene Proteins c-fos, Rats, Rats, Sprague-Dawley, Receptors, Dopamine D3, Tetrahydroisoquinolines, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17382304


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.